All Photos(1)



Citrate-phosphate-dextrose solution

aseptically filled



aseptically filled

Quality Level





storage temp.


Related Categories

General description

Citrate-phosphate-dextrose solution (CPD) is an anticoagulant solution. It has 15% less citrate ion over citrate-phosphate-dextrose solution with adenine (ACD) and provides improved isotonicity, oxygen release function and posttransfusion viability for red blood cells.


Citrate-phosphate-dextrose solution has been used as an anti-coagulant in bovine blood. It has also been used in the storage of fluorescein isothiocyanate (FITC) labeled erythrocytes. Citrate-phosphate-dextrose solution is suitable for erythrocyte survival studies and whole blood storage.

Other Notes

Suggested anticoagulant: whole blood ratio: 1:14

Storage Class Code

10 - Combustible liquids



Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificate of Analysis

Enter Lot Number to search for Certificate of Analysis (COA).

Certificate of Origin

Enter Lot Number to search for Certificate of Origin (COO).

  1. Which document(s) contains shelf-life or expiration date information for a given product?

    If available for a given product, the recommended re-test date or the expiration date can be found on the Certificate of Analysis.

  2. How do I get lot-specific information or a Certificate of Analysis?

    The lot specific COA document can be found by entering the lot number above under the "Documents" section.

  3. How do I find price and availability?

    There are several ways to find pricing and availability for our products. Once you log onto our website, you will find the price and availability displayed on the product detail page. You can contact any of our Customer Sales and Service offices to receive a quote.  USA customers:  1-800-325-3010 or view local office numbers.

  4. What is the Department of Transportation shipping information for this product?

    Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product. 

  5. For the anticoagulant Product C7165, Citrate-Phosphate-Dextrose solution, what is the proper anticoagulant to whole blood ratio to use?

    Our search of the literature shows that Citrate-Phosphate-Dextrose solution is typically used at a ratio of 1:7 or 1:9, but we do indeed test it at 1:14...the thinking being that if it works at 1:14, it will surely work at 1:7 or 1:9. The description of Product C7165, Citrate-Phosphate-Dextrose solution, suggests using it at an anticoagulant to whole blood ratio of 1.4 to 10 (about 1:7), but the specification sheet shows that it is tested at an anticoagulant to whole blood ratio of 1:14.

  6. My question is not addressed here, how can I contact Technical Service for assistance?

    Ask a Scientist here.

Citrate phosphate dextrose (CPD) anticoagulant in blood transfusion
McCullough J and Weiblen BJ
Minnesota Medicine, 56(11), 980-982 (1973)
J J Macoskey et al.
Physics in medicine and biology, 63(5), 055013-055013 (2018-02-10)
Histotripsy is an ultrasonic tissue ablation method based on acoustic cavitation. It has been shown that cavitation dynamics change depending on the mechanical properties of the host medium. During histotripsy treatment, the target-tissue is gradually fractionated and eventually liquefied to
C1-inhibitor reduces hepatic leukocyte-endothelial interaction and the expression of VCAM-1 in LPS-induced sepsis in the rat
Croner RS, et al.
Microvascular Research, 67(2), 182-191 (2004)
Mònica Arman et al.
Malaria journal, 7, 243-243 (2008-11-26)
Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes (IE) is a parasite adhesion phenotype that has been associated with severe malaria in some, but not all, field isolate studies. A variety of experimental conditions have been used to study clumping in vitro
Alexander P Duryea et al.
IEEE transactions on ultrasonics, ferroelectrics, and frequency control, 62(12), 2068-2078 (2015-12-17)
Remanent bubble nuclei generated by primary cavitation collapse can limit the efficiency of histotripsy softtissue fractionation. When these residual bubbles persist from one histotripsy pulse to the next, they can seed the repetitive nucleation of cavitation bubbles at a discrete

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service